Eph Receptor Tyrosine Kinases Are Functional Entry Receptors for Murine Gammaherpesvirus 68

Anna Katharina Großkopf1, Victor Tobiasson2, Laurie T Krug1

  • 1HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.

Insights

Murine gammaherpesvirus 68 (MHV68) uses Eph receptors, like EphA4 and EphB3, for cell entry. This interaction is conserved across species and targets neutralizing antibodies, supporting MHV68 as an in vivo infection model.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Viral glycoproteins and cellular receptors dictate virus tropism and are vaccine targets.
  • Eph receptor tyrosine kinases are known receptors for human gammaherpesviruses (KSHV, EBV), mediating entry via the viral gH/gL complex.
  • Murine gammaherpesvirus 68 (MHV68) is a rodent pathogen used to model early gammaherpesvirus infection events.

Purpose of the Study:

  • To characterize the interaction between the MHV68 gH/gL complex and Eph receptors.
  • To evaluate MHV68 as an in vivo model for gammaherpesvirus entry mechanisms.
  • To identify potential targets for therapeutic intervention against MHV68 infection.

Main Methods:

  • Direct interaction assays between MHV68 gH/gL and Eph receptors (EphA4, EphB3).
  • Infection studies using permissive and non-permissive cells, including those with ectopic Eph receptor expression.
  • Analysis of neutralizing antibodies targeting the MHV68 gH ectodomain, particularly domain I (D-I).
  • Protein structure predictions to guide targeted mutagenesis.

Main Results:

  • MHV68 gH/gL directly interacts with EphA4 and EphB3 receptors, conserved between human and murine Eph receptors.
  • Soluble decoy Eph receptors reduced MHV68 infection of fibroblasts.
  • Ectopic expression of EphA4 and EphB3 enabled MHV68 entry into non-permissive human B cells.
  • The MHV68 gH/gL-Eph interaction is mediated by domain I (D-I) of gH, consistent with KSHV.
  • Neutralizing antibodies targeting gH D-I significantly reduced MHV68 neutralization capacity.

Conclusions:

  • Eph receptors (EphA4, EphB3) are identified as novel interaction partners and entry receptors for MHV68.
  • The conserved entry mechanism involving Eph receptors provides a basis for in vivo studies of MHV68 infection.
  • The Eph-binding domain of gH is a key target for neutralizing antibodies, offering potential for vaccine development.